Indofarma Tbk PT


Indofarma Tbk PT

Health CarePharmaceuticals and Biotechnology
  • Price (IDR)985.00
  • Today's Change0.00 / 0.00%
  • Shares traded24.40k
  • 1 Year change-56.99%
  • Beta0.0445
Data delayed at least 10 minutes, as of Oct 03 2022 09:08 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • INAF:JKT price moved over -1.01% to 985.00

Key statistics

On Monday, Indofarma Tbk PT (INAF:JKT) closed at 985.00, 4.79% above its 52-week low of 940.00, set on Jul 04, 2022.
52-week range
940.00Jul 04 20222,650.00Nov 30 2021
Previous close985.00
Average volume93.64k
Shares outstanding3.10bn
Free float599.27m
P/E (TTM)--
Market cap3.07tn IDR
EPS (TTM)-41.76
Data delayed at least 10 minutes, as of Oct 03 2022 09:08 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.